ClinicalTrials.govpublic full text
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer
colorectal cancer, gastroesophageal cancer, nivolumab, ipilimumab, immune checkpoint blockade, mismatch repair, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 839804
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.